LA LEUCEMIE A TRICHOLEUCOCYTES. INCIDENCE DE LA TUBERCULOSE SUR 21 CASGUILHOT FRANCOIS.1980; ; FRA; DA. 1980; 121; 109-XXIX P.-PL.; 30 CM; BIBL. 21 REF.; TH.: MED./PARIS 5/1980Thesis

L'anti-tyrosine kinase : le début du traitement moléculaire des cancers et les premiers résultats : Le STI571 = Anti-tyrosine kinase : first results of initial molecular therapies of cancer diseasesGUILHOT, Francois.Bulletin du cancer. 2001, Vol 88, Num 7, pp 659-660, issn 0007-4551Article

Traitement moléculaire des cancers par l'inhibition des tyrosine-kinases = Molecular treatment of cancers by inhibition of tyrosine-kinasesLACOTTE-THIERRY, Laurence; GUILHOT, Francois.La Revue du praticien (Paris). 2002, Vol 52, Num 2, pp 121-123, issn 0035-2640Article

Les nouveaux essais thérapeutiques = The new therapeutic trialsGUILHOT, Francois.Hématologie (Montrouge). 2001, Vol 7, pp 29-34, issn 1264-7527, NSArticle

Current treatment strategies in chronic myeloid leukemiaGUILHOT, François; ROY, Lydia; TOMOWIAK, Cécile et al.Current opinion in hematology. 2012, Vol 19, Num 2, pp 102-109, issn 1065-6251, 8 p.Article

Blood consult: high Sokal risk chronic myeloid leukemia and suboptimal responseROY, Lydia; TOMOWIAK, Cécile; GUILHOT, François et al.Blood. 2011, Vol 118, Num 19, pp 5096-5098, issn 0006-4971, 3 p.Article

Efficacy of Imatinib Dose Escalation in Patients With Chronic Myeloid Leukemia in Chronic PhaseKANTARJIAN, Hagop M; LARSON, Richard A; GUILHOT, Francois et al.Cancer. 2009, Vol 115, Num 3, pp 551-560, issn 0008-543X, 10 p.Article

Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase. CommentaryGUILHOT, Francois; APPERLEY, Jane; HEIM, Dominik et al.Blood. 2007, Vol 109, Num 10, issn 0006-4971, 4110, 4143-4150 [9 p.]Article

Clinical and biological features at diagnosis in 40 children with chronic myeloid leukemiaMILLOT, Frédéric; TRAORE, Philippe; GUILHOT, Joelle et al.Pediatrics (Evanston). 2005, Vol 116, Num 1, pp 140-143, issn 0031-4005, 4 p.Article

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemiaO'BRIEN, Stephen G; GUILHOT, Francois; LECHNER, Klaus et al.The New England journal of medicine. 2003, Vol 348, Num 11, pp 994-1004, issn 0028-4793, 11 p.Article

Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cellsDEUTSCH, Eric; JARROUSSE, Sylvie; BUET, Dorothée et al.Blood. 2003, Vol 101, Num 11, pp 4583-4588, issn 0006-4971, 6 p.Article

Single versus double autologous stem-cell transplantation for multiple myelomaATTAL, Michel; HAROUSSEAU, Jean-Luc; VOILLAT, Laurent et al.The New England journal of medicine. 2003, Vol 349, Num 26, pp 2495-2502, issn 0028-4793, 8 p.Article

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With ImatinibGAMBACORTI-PASSERINI, Carlo; ANTOLINI, Laura; D'EMILIO, Anna et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 7, pp 553-561, issn 0027-8874, 9 p.Article

Diagnosis and management of chronic myeloid leukemia : A survey of american and european practice patternsKANTARJIAN, Hagop M; CORTES, Jorge; GUILHOT, Francois et al.Cancer. 2007, Vol 109, Num 7, pp 1365-1375, issn 0008-543X, 11 p.Article

Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia with resistance or intolerance to imatinib : interim results of a phase 2 studyOTTMANN, Oliver; DOMBRET, Hervé; GOLLERKERI, Ashwin et al.Blood. 2007, Vol 110, Num 7, pp 2309-2315, issn 0006-4971, 7 p.Article

Stratégies thérapeutiques et recommandations pour la prise en charge des patients atteints de leucémie myéloïde chronique = Treatment and monitoring of patients with chronic myeloid leukemiaBORIES, Dominique; DEVERGIE, Agnès; ROUSSELOT, Philippe et al.Hématologie (Montrouge). 2003, Vol 9, Num 6, pp 497-512, issn 1264-7527, 16 p.Article

Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phaseGARDEMBAS, Martine; ROUSSELOT, Philippe; MALOISEL, Frederic et al.Blood. 2003, Vol 102, Num 13, pp 4298-4305, issn 0006-4971, 8 p.Article

Imatinib in combination with cytarabine for the treatment of Philadelphia-positive chronic myelogenous leukemia chronic-phase patients: Rationale and design of phase I/II trialsGUILHOT, Francois; GARDEMBAS, Martine; NAJMAN, Albert et al.Seminars in hematology. 2003, Vol 40, Num 2, pp 92-97, issn 0037-1963, 6 p., SUP2Conference Paper

Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis. CommentaryGOLDMAN, John; CORTES, Jorge; APPERLEY, Jane et al.Blood. 2007, Vol 109, Num 8, issn 0006-4971, 3128,3207-3213 [8 p.]Article

Results of a phase II trial testing interferon-alpha 2b and cytarabine in children and adolescents with chronic myelogenous leukemiaMILLOT, Frédéric; GUILHOT, Joelle; DUCHENE, Sylvain et al.Pediatric blood & cancer. 2006, Vol 47, Num 5, pp 555-559, issn 1545-5009, 5 p.Article

BCR/ABL promotes dendritic cell-mediated natural killer cell activationTERME, Magali; BORG, Christophe; ZITVOGEL, Laurence et al.Cancer research (Baltimore). 2005, Vol 65, Num 14, pp 6409-6417, issn 0008-5472, 9 p.Article

High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients : correlation with clonal cytogenetic evolution but not response to therapy. CommentaryWILLIS, Stephanie G; LANGE, Thoralf; DRUKER, Brian J et al.Blood. 2005, Vol 106, Num 6, pp 1897-1898, issn 0006-4971, 12 p.Article

Risk factors analysis for Pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumoniaROBLOT, France; IMBERT, Sabrina; GUILHOT, Francois et al.Scandinavian journal of infectious diseases. 2004, Vol 36, Num 11-12, pp 848-854, issn 0036-5548, 7 p.Article

Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemiaSOLARY, Eric; DRENOU, Bernard; HUNAULT-BERGER, Mathilde et al.Blood. 2003, Vol 102, Num 4, pp 1202-1210, issn 0006-4971, 9 p.Article

α-interferon in combination with cytarabine in children with Philadelphia chromosome-positive chronic myeloid leukemiaMILLOT, Frédéric; BRICE, Pauline; GUILHOT, Francois et al.Journal of pediatric hematology/oncology. 2002, Vol 24, Num 1, pp 18-22, issn 1077-4114Article